65,437 trials
Obesity · Metabolic Syndrome · Lifestyle Intervention
Primary: Number and Percentage of Men Achieving 5% Weight Loss or More — 37; 51 Participants
Syncope
Primary: Patients With Recurrence of Syncopal Episode — 10; 34 Participants — p=<0.001
Advanced Cancer
Primary: Phase 1A: Number of Participants Experiencing Adverse Events (AEs) — 114 Participants
Rheumatoid Arthritis
Primary: American College of Rheumatology(ACR)20 Response Rate at Week 24. — 268; 268 Participants
Advanced Solid Tumors
Primary: Number of Participants With Dose Limiting Toxicities (DLTs) of CPX-POM — 0; 0; 0; 0 participants
Rheumatoid Arthritis
Primary: The Usability as Assessed by Patients Rating Using PRE- and POST-Self-Injection Assessment Questionnaire (SIAQ) at Week 4 — 8.00; 8.16; 6.55; 7.07 scores on a scale
Heart Failure With Preserved Ejection Fraction (HFpEF)
Primary: Change From Baseline in Kansas-City Cardiomyopathy Questionnaire-Total Symptom Score (KCCQ-TSS) at Week 16 (Higher Scores Represent Less HF Symptom Frequency and Burden)…
Influenza · Respiratory Tract Infections · Vaccines
Primary: 1.Receipt of the Annual Influenza Vaccine (Between 10/1/18 - 4/2/19) Among Index Patients. Outcomes Will be Assessed Via Vaccine Data Extraction From the Electronic…
Parkinson's Disease
Primary: Unified Parkinson's Disease Rating Scale (UPDRS) Change — 21.25; 22.4; 20.8; 22.31 units on a scale
Dietary Habits
Primary: Change in Carotenoid Levels Over Time
Infertility
Primary: Patient Tolerability and Satisfaction SF36 — 76.8; 84.2 units on a scale
Adjunctive Treatment of Major Depressive Disorder
Primary: Change From Baseline to Week 5 in Hamilton Depression Scale (17 Items) (HAMD-17) Total Score — -9.0; -8.1 score on a scale — p=0.2956
Migraine
Primary: Cmax — 11670; 9861; 11680; 3705 pg/mL
Prader-Willi Syndrome
Primary: Hyperphagia Behavior — -3.439; -5.372; -2.237 score on a scale — p=0.3493
HIV Positive
Primary: Number of Participants With Virologic Failure With OLA-guided ART vs. Standard of Care — 34; 39 Participants